Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 138 | $77,751,392 |
Sells | 179 | $97,046,544 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 100 | 284.65 | 28,465 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 400 | 283.43 | 113,372 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 400 | 282.13 | 112,852 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 1,000 | 280.92 | 280,920 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 2,620 | 279.96 | 733,495 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 3,003 | 279.15 | 838,287 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 700 | 277.83 | 194,481 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 700 | 276.67 | 193,669 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 811 | 275.7 | 223,593 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 3,019 | 274.56 | 828,897 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 2,471 | 273.54 | 675,917 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 5,534 | 272.68 | 1,509,011 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 2,084 | 271.54 | 565,889 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 2,069 | 270.56 | 559,789 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 1,476 | 269.61 | 397,944 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 1,913 | 268.5 | 513,640 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 1,107 | 267.47 | 296,089 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 593 | 266.04 | 157,762 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 200 | 283.61 | 56,722 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 200 | 281.79 | 56,358 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 200 | 280.41 | 56,082 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 1,100 | 279.46 | 307,406 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 361 | 277.77 | 100,275 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 100 | 276.4 | 27,640 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 100 | 275.24 | 27,524 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 400 | 274.7 | 109,880 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 539 | 273.48 | 147,406 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 1,500 | 272.74 | 409,110 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 800 | 271.27 | 217,016 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 700 | 270.25 | 189,175 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 300 | 268.99 | 80,697 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 500 | 267.88 | 133,940 | D |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 100 | 287.86 | 28,786 | D |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 400 | 286.62 | 114,648 | D |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 2,038 | 285.74 | 582,338 | D |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 829 | 285.15 | 236,389 | D |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 1,549 | 283.85 | 439,684 | D |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 2,628 | 282.97 | 743,645 | D |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 2,656 | 281.97 | 748,912 | D |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 1,800 | 280.66 | 505,188 | D |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 400 | 279.1 | 111,640 | D |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 600 | 277.91 | 166,746 | D |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 500 | 296.68 | 148,340 | D |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 2,325 | 295.45 | 686,921 | D |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 5,164 | 294.68 | 1,521,728 | D |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 3,548 | 293.54 | 1,041,480 | D |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 5,227 | 292.68 | 1,529,838 | D |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 3,325 | 291.66 | 969,770 | D |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 1,600 | 290.36 | 464,576 | D |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 300 | 288.91 | 86,673 | D |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 400 | 287.08 | 114,832 | D |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 100 | 285.28 | 28,528 | D |
02 Mar 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 28 Feb 2023 | Sale | 4,100 | 272.3 | 1,116,430 | D |
02 Mar 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 28 Feb 2023 | Sale | 900 | 271.03 | 243,927 | D |
02 Mar 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 01 Mar 2023 | Sale | 100 | 276.19 | 27,619 | D |
02 Mar 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 01 Mar 2023 | Sale | 1,300 | 275.53 | 358,189 | D |
02 Mar 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 01 Mar 2023 | Sale | 1,672 | 274.57 | 459,081 | D |
02 Mar 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 01 Mar 2023 | Sale | 1,928 | 273.44 | 527,192 | D |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 26,426 | 146.2104 | 3,863,756 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 2,228 | 146.2104 | 325,757 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 2,994 | 145.9775 | 437,057 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 252 | 145.9775 | 36,786 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 6,369 | 145.4592 | 926,430 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 537 | 145.4592 | 78,112 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 1,291 | 142.8575 | 184,429 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 109 | 142.8575 | 15,571 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 10,790 | 141.445 | 1,526,192 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 910 | 141.445 | 128,715 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 5,072 | 140.9024 | 714,657 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 427 | 140.9024 | 60,165 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 4,631 | 137.6855 | 637,622 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 3,693 | 136.9089 | 505,605 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 390 | 137.6855 | 53,697 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 311 | 136.9089 | 42,579 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 3,144 | 136.1805 | 428,151 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 265 | 136.1805 | 36,088 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 13,548 | 154.7801 | 2,096,961 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 1,142 | 154.7801 | 176,759 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 683 | 153.9736 | 105,164 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 8,098 | 153.9736 | 1,246,878 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 2,877 | 153.2523 | 440,907 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 242 | 153.2523 | 37,087 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 646 | 152.2129 | 98,330 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 54 | 152.2129 | 8,219 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 6,022 | 152.48 | 918,235 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 507 | 152.48 | 77,307 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 299 | 154.5969 | 46,224 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 3,542 | 154.5969 | 547,582 | I |
15 Nov 2023 17:13 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 31,530 | 156.4244 | 4,932,061 | I |
15 Nov 2023 17:13 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 2,658 | 156.4244 | 415,776 | I |
15 Nov 2023 17:13 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 15 Nov 2023 | Purchase | 14,018 | 161.966 | 2,270,439 | I |
15 Nov 2023 17:13 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 15 Nov 2023 | Purchase | 1,181 | 161.966 | 191,282 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 10,715 | 175.8179 | 1,883,889 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 903 | 175.8179 | 158,764 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 4,923 | 175.7185 | 865,062 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 415 | 175.7185 | 72,923 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 18,125 | 174.8748 | 3,169,606 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 1,528 | 174.8748 | 267,209 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 978 | 174.6698 | 170,827 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 1,660 | 173.7481 | 288,422 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)